Lightning Round: This bargain stock goes to $100

It's that time again! The Lightning Round bell has rung, and Jim Cramer gives his take on a few favorite audience stocks:

Bristol-Myers Squibb: "We have been a buyer of Bristol-Myers ever since we started the show. Bristol-Myers remains on the buy list."

Orbital ATK: "Right now Lockheed Martin, and then Orbital ATK, and then Northrup Grumman and then perhaps even Harris Corp. above General Dynamics."

Symantec: "It's okay. Honestly if you want to buy security software I'm going to send you to a pure play like Palo Alto Networks, CyberArk or as a blended play I will do Cisco."

Hortonworks, Inc: "An open sourced platform will send me to Red Hat, which hasn't come in and I kept hoping it would come in."

Dunkin' Brands Group: "Here's the problem, Dunkin' had a big move and that was a good quarter. I do prefer Starbucks to Dunkin' Donuts, although at the local level I try to throw in both businesses because you have to be equal...But I like both those stocks, and Dunkin' is probably going higher."

Flotek Industries: "I think Flotek is too cheap. The rest of that group has started to move up and that stock hasn't moved up yet. They do some absolutely terrific fracking chemicals, the problem is of course that there are fewer wells being drilled but you have to start thinking that there will be more wells being drilled now that oil has gone back to $60 and Boone Pickens has said it is going to $70."

American Tower Corp: "We like it in the mid $90s. I think it's a bargain and the stock can go to $100."

Baytex Energy Corp: "No...I'm willing to even do some drillers. But not the trust."

----------------------------------------------------------
Read more from Mad Money with Jim Cramer
Cramer: The strongest stock in the game
Cramer: Profit on this massive rotation
Cramer: Cisco takes no prisoners
----------------------------------------------------------

BioDelivery Sciences International Inc: "It's one of these development stage companies, and a lot of people are selling all of those. Remember...they went away from the big biotech specs a long time ago, which is why we pulled in the horns and said we like BioMarin, Receptos and Radius. Those are our three for the moment."

Juno Therapeutics: "Juno is like Halo, again that is very speculative stuff. I totally have to take a long-term view—someone is going to win in that personalized medicine category."

CarMax: "I like CarMax and I like AutoNation too. CarMax is extraordinarily and let me tell you, when you think of retailers it wouldn't be so bad to own either CarMax or AutoNation."

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram - Vine

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com

Cramer's New Book